1.Mittal S,
Wu Z,
Neelavalli J,
et al.
Susceptibility-weighted imaging:
technical aspects and clinical applications,
part 2.
AJNR Am J
Neuroradiol 2009;30:232-252.
2.
Thomas B,
Somasundaram S,
Thamburaj K,
et al.
Clinical applications of susceptibility weighted MR imaging of the brain – a
pictorial review.
Neuroradiology 2008;50:105-116.
3.
Haacke EM,
Mittal S,
Wu Z,
et al.
Susceptibility-weighted imaging:
technical aspects and clinical applications,
part 1.
AJNR Am J
Neuroradiol 2009;30:19-30.
4.
Wu Z,
Mittal S,
Kish K,
et al.
Identification of calcification with
MRI using susceptibility-weighted imaging: a case study.
J Magn
Reson Imaging 2009;29:177-182.
5.
Rauscher A,
Sedlacik J,
Barth M,
et al.
Magnetic susceptibilityweighted
MR phase imaging of the human brain.
AJNR Am J Neuroradiol
2005;26:736-742.
6.
Tong KA,
Ashwal S,
Holshouser BA,
et al.
Diffuse axonal injury in
children: clinical correlation with hemorrhagic lesions.
Ann Neurol
2004;56:36-50.
7.
Tong KA,
Ashwal S,
Holshouser BA,
et al.
Hemorrhagic shearing
lesions in children and adolescents with posttraumatic diffuse
axonal injury: improved detection and initial results.
Radiology
2003;227:332-339.
8.
Chastain CA,
Oyoyo U,
Zipperman M,
et al.
Predicting outcomes
of traumatic brain injury by imaging modality and injury distribution.
J Neurotrauma 2009;26:1183-1196.
9.
Babikian T,
Freier MC,
Tong KA,
et al.
Susceptibility weighted
imaging: neu-ropsychologic outcome and pediatric head injury.
Pediatr Neurol 2005;33:184-194.
10.
Gao T,
Wang Y,
Zhang Z.
Silent cerebral microbleeds on
susceptibility-weighted imaging of patients with ischemic stroke
and leukoaraiosis.
Neurol Res 2008;30:272-276.
11.
Fushimi Y,
Miki Y,
Mori N,
et al.
Signal changes in the brain
on susceptibility-weighted imaging under reduced cerebral blood
flow: a preliminary study.
J Neuroimaging 2009;20:255-259.
12.
Ghostine S,
Raghavan R,
Khanlou N,
et al.
Cerebral amyloid
angiopathy: micro-haemorrhages demonstrated by magnetic
Robinson,
Bhuta: Susceptibility-Weighted Imaging of the Brain 15
resonance susceptibility-weighted imaging.
Neuropathol Appl Neurobiol
2009;35:116-119.
13.
Haacke EM,
DelProposto ZS,
Chaturvedi S,
et al.
Imaging cerebral
amyloid angiopathy with susceptibility-weighted imaging.
AJNR Am
J Neuroradiol 2007;28:316-317.
14.
de Souza JM,
Domingues RC,
Cruz LC,
et al.
Susceptibilityweighted
imaging for the evaluation of patients with familial cerebral
cavernous malformations: a comparison with t2-weighted fast
spin-echo and gradient-echo sequences.
AJNR Am J Neuroradiol
2008;29:154-158.
15.
Cooper AD,
Campeau NG,
Meissner I.
Susceptibility-weighted
imaging in familial cerebral cavernous malformations.
Neurology
2008;71:382.
16.
Boukobza M,
Crassard I,
Bousser MG,
et al.
MR imaging features
of isolated cortical vein thrombosis: diagnosis and follow-up.
AJNR
Am J Neuroradiol 2009;30:344-348.
17.
Duncan IC,
Fourie PA.
Imaging of cerebral isolated cortical vein
thrombosis.
Am J Roentgenology 2005;184:1317-1319.
18.
Drayer B,
Burger P,
Darwin R,
et al.
MRI of brain iron.
Am J
Roentgenology 1986;147:103-110.
19.
Hayflick SJ,
Hartman M,
Coryell J,
et al.
Brain MRI in neurodegeneration
with brain iron accumulation with and without PANK2
mutations.
AJNR Am J Neuroradiol 2006;27:1230-1233.
20.
Adachi M,
Hosoya T,
Haku T,
et al.
Evaluation of the substantia
nigra in patients with Parkinsonian syndrome accomplished using
multishot diffusion-weighted MR imaging.
AJNR Am J Neuroradiol
1999;20:1500-1506.
21.
Haacke EM,
Makki M,
Ge Y,
et al.
Characterizing iron deposition
in multiple sclerosis lesions using susceptibility weighted imaging.
J Magn Reson Imaging 2009;29:537-544.
22.
Kim HS,
Jahng G-H,
Ryu CW,
et al.
Added value and diagnostic
performance of intratumoral susceptibility signals in the differential
diagnosis of solitary enhancing brain lesions: preliminary study.
AJNR Am J Neuroradiol 2009.
[Epub ahead of print].
23.
Haimes AB,
Zimmerman RD,
Morgello S,
et al.
MR imaging of
brain abscesses.
AJR Am J Roentgenol 1989;152:1073-1085.
24.
Pinker K,
Noebauer-Huhmann IM,
Stavrou I,
et al.High-resolution
contrast-enhanced,
susceptibility-weighted MR imaging at 3T in
patients with brain tumors: correlation with positron-emission tomography
and histopathologic findings.
AJNR Am J Neuroradiol
2007;28:1280-1286.
25.
Erdag N,
Bhorade RM,
Alberico RA,
et al.
Primary lymphoma
of the central nervous system: typical and atypical CT and MR
imaging appearances.
Am J Roentgenology 2001;176:1319-1326.
26.
Kesavadas C,
Thomas B,
Misra S,
et al.
Attenuation of cerebral
veins in susceptibility-weighted MR imaging performed with
the patient under general anesthesia.
AJNR Am J Neuroradiol
2008;29:e71
27.Robinson RJ,
Bhuta S,J of Neuroimaging.
2011 Jan 31.
doi: 10.1111/j.1552-6569.2010.00516.[Epub ahead of print],Susceptibility-Weighted Imaging of the Brain: Current Utility and Potential Applications